C.01
Dose Transparency
w × 14 · score 9
Pet Gala earns a perfect dose transparency score, calculated by a deterministic scoring function, because the product page discloses individual active doses for all 13 active ingredients alongside a clearly stated serving size, with no proprietary blends obscuring any meaningful amount. This formulation architecture satisfies every element of the LPL-01 Standard's 10/10 anchor: buyers can verify whether each skin, coat, nail, and barrier-support ingredient reaches a functionally relevant level without inference or estimation. There are no gaps to note at this tier. Re-scored 9/10 under strict anchors (2026-07-03): Score stops below 10 because the omega blend is disclosed as a combined ‘Omega 3-6-9 150 mg’ figure without an EPA/DHA split; the tier-10 anchor requires individual active-dose disclosure for every meaningful active. Publishing the per-fatty-acid breakdown would earn the 10.
C.02
Integumentary System Coverage
w × 16 · score 9
The deterministic scoring function awarded a 9/10 because the formulation architecture spans at least five distinct integumentary domains — skin barrier lipids (Omega 3-6-9, Omega-7, Ceramides), hydration (Hyaluronic Acid, Ceramides), dermal structure (Marine Collagen Peptides, Hydrolyzed Whey Protein, Beef Gelatin, Bone Broth), coat fiber quality (Biotin, Zinc, MSM), and keratin and nail support (Biotin, Zinc, Silica) — with clear role separation across each. The one gap preventing a perfect mark is follicle-specific pathway coverage: follicular support is implied through overlapping nutrients rather than addressed as a documented, discrete mechanism within the formula's stated architecture.
C.03
Barrier Lipid And Hydration Architecture
w × 14 · score 10
The deterministic scoring function awarded a full 10/10 because this formula demonstrates exactly the coherent barrier-and-hydration architecture the LPL-01 Standard requires: Omega 3-6-9 (150 mg) and Omega-7 (50 mg) address barrier-lipid replenishment through distinct fatty-acid pathways, while Ceramides (8 mg) and Hyaluronic Acid (50 mg) reinforce the lipid matrix and dermal hydration layer respectively. Dose transparency is complete across all four ingredients, and the role separation between lipid-supply and hydration-retention mechanisms reflects deliberate formulation architecture rather than cosmetic label padding. No gaps in pathway coverage or disclosure prevented a perfect score.
C.04
Dermal Matrix, Collagen And Coat-Fiber Support
w × 14 · score 10
The deterministic scoring function awarded a perfect 10/10 because this formula meets every condition of the 10/10 anchor without exception. Marine Collagen Peptides (500 mg), Hydrolyzed Whey Protein (250 mg), Beef Gelatin (200 mg), and Bone Broth (100 mg) represent a coherent dermal-matrix architecture with full dose transparency, meaningful pathway coverage across collagen substrate supply, amino acid density, and connective-tissue scaffolding, and clear role separation between each ingredient — satisfying the LPL-01 Standard for structural-support formulation design.
C.05
Keratin, Nail And Follicle Nutrient Logic
w × 10 · score 9
The deterministic scoring function awarded a 9/10 because the formulation presents a coherent keratin-support architecture — Biotin (50 mcg), Zinc (1.5 mg), Silica (10 mg), and MSM (100 mg) — with each ingredient disclosed at a specific dose and traceable to normal keratin formation, coat renewal, and nail strength under the LPL-01 Standard. Pathway coverage across sulfur donation, mineral cofactors, and structural silica is genuinely strong. The score stops at 9 rather than 10 because follicle-targeting rationale is not separated from broader coat-renewal language, leaving buyers unable to distinguish follicle-specific intent from general keratin support.
C.06
Testing Transparency
w × 12 · score 9
Testing transparency here is strong: third-party verification through NSF and Eurofins covers heavy metals, microbial safety, label accuracy, potency, and batch-level consistency, and a public COA lookup tool exists at a dedicated page — well above the threshold for a 7. The score stops at 9 rather than 10 because the deterministic scoring function identified one remaining gap: the COA lookup experience is not yet confirmed to be fully batch-linked at point of purchase across every current SKU, meaning a buyer receiving a specific lot cannot always close the verification loop in a single step.
C.07
Evidence Quality And Species-Appropriate Claim Discipline
w × 10 · score 9
Claim discipline here is notably strong: Pet Gala is positioned as beauty-nutrition support rather than a dermatological treatment, with no disease, allergy, or dermatitis-adjacent language present, and species-appropriate dosing logic explicitly excludes puppies, kittens, and pregnant or lactating animals — all markers the deterministic scoring function rewards. The score stops at 9 rather than 10 because finished-formula clinical evidence in dogs and cats on the daily Pet Gala formulation has not yet been published, leaving ingredient-level science as the primary evidence layer rather than confirmed finished-product outcomes.
C.08
Daily Usability, Palatability And Owner Compliance
w × 10 · score 9
The score of 9/10 was calculated from source-backed attributes reflecting a well-structured daily-use format: pre-measured powder sachets with clear feeding guidance and a savory chicken-and-chicken-liver palatability system meaningfully reduce daily friction and support the multi-week consistency required for visible coat, skin, and nail changes. Subscription cadence further reinforces long-term routine fit across varied diet styles. The single point withheld reflects the minor but real friction of mixing powder into food daily — chew or liquid formats carry lower per-dose effort for some owners, and palatability acceptance, while designed for broad appeal, cannot be fully guaranteed across individual animals.